In addition, various tumor suppressors including p53, phosphatase and tensin homolog (PTEN), breast cancer 1, early onset (BRCA1) and BRCA2 are frequently truncated as a result of genomic rearrangements in prostate cancer progression. The gene discussed is PTEN; the disease is breast carcinoma.